Joined the board and appointed chairman in 2008
Chairman of the Remuneration Committee
Chairman of the Nomination Committee
Member of the Strategy Committee
No. of shares in GN:
Member of the boards in BioMalta, Exiqon A/S, Medicine for Malaria Venture, Gilead Sciences Inc., Novo A/S
Retired, President Merck & Co., Inc., US Intercontinental Division
Per brings a unique set of capabilities and values to the board of GN Store Nord within marketing, product development as well as commercialization of innovation
Per has an extensive global leadership expertise and knowledge of the healthcare industry from his many years at the leadership team of Merck & Co., Inc. - a US based Fortune 500 company. Per also possesses in depth knowledge of the US market as well as emerging markets.
Per holds an MBA, and he started his career as Managing Director in the pharmaceutical company MSD Norway from 1976-1991. From 1991, Per worked in Merck & Co., Inc. in various assignments of increasing responsibility. From 1994 to 2006 Per was a member of Merck’s Management Committee.
Complies with the Committee on Corporate Governance’s definition of independency